Long-term efficacy and safety of intravitreal dexamethasone implant for the treatment of diabetic macular edema.

Purpose: To evaluate the long-term efficacy and safety of the dexamethasone intravitreal implant Ozurdex® in the treatment of diabetic macular edema (DME).

Methods: This was a retrospective noncomparative study. A total of 23 patients with DME followed for at least 12 months were included.

Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema.

Purpose: To evaluate the efficacy and safety of intravitreal implant of dexamethasone (Ozurdex®) in diabetic macular edema (DME).

Methods: This was a retrospective multicenter noncomparative study. Seventy-eight patients with DME followed for at least 6 months were included (P1.